NAD+ Nasal Spray: Does It Work? Evidence, Dosage & Side Effects (2026)

Key Takeaways

• No published clinical trial has tested NAD+ nasal spray in humans for any outcome. No pharmacokinetic study has measured blood or brain NAD+ levels after intranasal NAD+ application.
• The intranasal route has proven absorption for other drugs (insulin at 5,808 Da, oxytocin at 1,007 Da, various migraine medications). NAD+ at 663 Da is within the molecular weight range where nasal absorption is plausible but unproven.
• The nose-to-brain pathway is the main theoretical attraction. If NAD+ can travel along the olfactory nerve directly to the brain, it could support neurological applications that oral supplements cannot reach. This has not been demonstrated for NAD+.
• Oral NMN and NR remain the evidence-supported method for raising NAD+ levels. The Berven 2026 pharmacokinetic study found that neither oral NMN nor oral NR raised brain NAD+ after 8 days, though NR did after 4 weeks. Nasal spray has not been compared.

What Is NAD+ Nasal Spray?

NAD+ nasal spray is a liquid formulation of NAD+ designed to be sprayed into the nostrils. Each pump delivers a metered dose (typically 10 mg per spray) through the nasal mucosa, a thin, blood-vessel-rich tissue that lines the inside of the nose. The product is sold by compounding pharmacies and specialty supplement retailers, usually at concentrations of 50 to 100 mg per mL in a metered-dose nasal spray bottle.

The concept is borrowed from pharmaceutical intranasal delivery, which has a legitimate track record. Migraine medications (zolmitriptan, sumatriptan), hormone therapies (oxytocin, desmopressin), and even insulin have all been successfully delivered through the nose in published clinical trials. The nasal route avoids first-pass liver metabolism, offers rapid absorption into the bloodstream, and may provide a direct pathway to the central nervous system via the olfactory and trigeminal nerve endings.

NAD+ nasal sprays typically come in a metered-dose pump bottle, similar in appearance to an allergy nasal spray. Each pump is calibrated to release a fixed volume, and the product is usually stored refrigerated because NAD+ degrades with heat and time. Some formulations combine NAD+ with other ingredients marketed for cognitive or energy support, such as B vitamins or nootropic compounds, which adds further variables to an already unproven product.

The target audience is generally people who dislike swallowing capsules, want faster onset than oral supplements provide, or are specifically drawn to the brain-access claim. Those are reasonable motivations. The question is whether the product delivers on them, and that is where the evidence gap becomes the whole story.

The question is whether NAD+ behaves the same way through this route. The answer, as of September 2026, is that nobody has checked.

Does NAD+ Nasal Spray Work?

We genuinely do not know. That's not a hedge or a cautious framing. It reflects the complete absence of published human data.

No study has sprayed NAD+ into a person's nose and then measured blood NAD+ levels afterward. No study has measured brain NAD+ levels after intranasal NAD+ administration. No study has compared intranasal NAD+ to oral NMN, oral NR, or injectable NAD+ in the same trial. No study has measured any clinical outcome (energy, cognition, sleep, exercise performance) from NAD+ nasal spray in a controlled setting.

What exists is a theoretical basis built from two pillars.

It's worth being precise about what "no evidence" means here, because it's easy to misread. It does not mean studies were done and found the spray ineffective. It means the studies simply have not been done. NAD+ nasal spray could turn out to work well, work modestly, or not work at all, and right now there is no data to distinguish between those outcomes. That uncertainty is the honest state of the science, and it's very different from a product that has been tested and failed. It's a product that has not been tested.

The first pillar: intranasal delivery works for other molecules. The nasal mucosa has a large surface area, rich blood supply, and thin epithelium. Drugs delivered this way can reach systemic circulation within minutes. The question is whether NAD+ at 663 Da, hydrophilic and charged, can cross this barrier effectively. NAD+ is smaller than insulin (5,808 Da), which has demonstrated intranasal absorption, but NAD+ is also charged at physiological pH, which reduces mucosal permeability. The answer depends on formulation-specific factors (penetration enhancers, pH buffering, spray particle size) that vary by product and have not been published for any NAD+ nasal spray.

The second pillar: the nose-to-brain pathway. The olfactory nerve endings in the upper nasal cavity connect directly to the olfactory bulb in the brain, bypassing the blood-brain barrier. Some molecules delivered intranasally have been shown to travel this route and reach brain tissue at concentrations higher than systemic administration achieves. If NAD+ could do this, it would have implications for neurodegeneration research, since brain NAD+ depletion is linked to Alzheimer's and Parkinson's disease in published models.

But "could" and "does" are different words. The Berven 2026 pharmacokinetic study measured brain NAD+ after oral NMN and NR supplementation and found that neither raised brain NAD+ after 8 days. NR did raise brain NAD+ after 4 weeks. If oral precursors struggle to reach the brain quickly, the nasal route might theoretically be faster. That's a hypothesis worth testing. It hasn't been tested.

How Nose-to-Brain Delivery Actually Works

To understand whether NAD+ nasal spray can do what it claims, you need to understand the three separate routes a molecule can take after you spray it into your nose. They are not equivalent, and only one of them delivers on the "direct to brain" promise.

The nasal cavity is a pair of narrow chambers about 12 to 14 centimeters long, lined with mucosa, with a total surface area of roughly 150 square centimeters (Qiu et al., 2025). That mucosa is divided into functional zones, and where a sprayed molecule lands determines what happens to it.

Route 1: the respiratory pathway (systemic absorption). Most of your nasal lining is respiratory epithelium, rich in blood vessels. Molecules absorbed here enter the bloodstream, bypassing the digestive tract and liver first-pass metabolism. This is real and useful, but it is not "nose-to-brain." A molecule absorbed this way still has to cross the blood-brain barrier to reach the brain, exactly like an oral or injected drug. For NAD+, this route offers no advantage over injection in terms of brain access.

Route 2: the olfactory pathway (direct to brain). This is the one that matters for the marketing claim. The olfactory epithelium sits high in the nasal cavity, at the roof, and its neurons connect directly to the olfactory bulb in the brain. A molecule that deposits here and gets taken up by olfactory neurons can travel along the nerve directly into brain tissue, bypassing the blood-brain barrier entirely. Studies report brain exposure within minutes and cerebral distribution within 30 minutes for molecules that successfully use this route.

Route 3: the trigeminal pathway. The trigeminal nerve also innervates the nasal cavity and provides a second, slower route to the brain. It contributes to nose-to-brain transport but is less studied than the olfactory route.

Here is the problem that nasal spray marketing skips over: the olfactory epithelium makes up only a small fraction of the total nasal surface area, and it sits at the very top of the nasal cavity, which is the hardest place for a spray to reach. Most of what you spray lands on respiratory epithelium (Route 1, systemic) or gets swept away before it can be absorbed at all. Reaching the olfactory region in meaningful quantity is a genuine formulation challenge that even pharmaceutical companies with validated intranasal drugs struggle to solve.

The Mucociliary Clearance Problem

Your nose is designed to get rid of foreign substances, and it is very good at its job. This is the single biggest obstacle to any nasal spray, including NAD+.

The nasal mucosa is covered in cilia, tiny hair-like structures that beat in a coordinated wave to sweep mucus (and anything trapped in it) toward the back of the throat, where it gets swallowed. This mucociliary clearance system replaces the entire nasal mucus layer roughly every 15 to 20 minutes. Anything you spray into your nose is on a clock: if it does not get absorbed within that window, it gets cleared into your digestive tract, where it is then subject to exactly the same degradation that limits oral NAD+.

For a molecule to beat mucociliary clearance, it needs to either absorb very quickly or stick to the mucosa long enough to be taken up. NAD+ faces problems on both counts. It is hydrophilic and charged, which slows its passage across the epithelial barrier (the same issue that limits its skin absorption in patches). And unless the formulation includes mucoadhesive agents to make it stick, it is likely to be cleared before significant amounts cross into either the bloodstream or the olfactory neurons.

A 2025 review in MedComm (Qiu et al.) examining nose-to-brain delivery noted that hydrophilic molecules must traverse the tight junctions between nasal epithelial cells, a barrier that lipophilic molecules bypass more easily. NAD+ is hydrophilic. This does not make nasal absorption impossible, but it means an unformulated NAD+ solution sprayed into the nose faces a steep uphill battle, and no published study has measured how much actually gets through for NAD+ specifically.

What Would Make a NAD+ Nasal Spray Actually Work?

Pharmaceutical researchers working on nose-to-brain delivery have developed several strategies to overcome the barriers above. Whether any consumer NAD+ nasal spray uses them is almost never disclosed, but knowing what real solutions look like helps you evaluate the products.

Mucoadhesive formulations. Adding polymers that stick to the nasal mucosa extends the contact time, giving the molecule longer to absorb before mucociliary clearance sweeps it away. Chitosan is a commonly studied mucoadhesive that also transiently loosens epithelial tight junctions to improve hydrophilic molecule transport.

Lipid nanoparticles. Encapsulating the active molecule in solid lipid nanoparticles or nanostructured lipid carriers can improve stability and help hydrophilic compounds cross the epithelium. Much of the recent nose-to-brain research focuses on these nanocarrier systems precisely because unformulated hydrophilic drugs absorb so poorly.

Stimuli-responsive gels. Formulations that are liquid when sprayed but gel on contact with the nasal mucosa resist clearance better than plain solutions.

Devices that target the olfactory region. Specialized nasal delivery devices can direct spray toward the upper nasal cavity where the olfactory epithelium sits, rather than depositing it in the lower respiratory region.

The key question for any NAD+ nasal spray you are considering: does it use any of these technologies, and has the manufacturer published data showing the formulation delivers NAD+ across the nasal mucosa? As of September 2026, no consumer NAD+ nasal spray has published such data. Most are simple NAD+ solutions in a spray bottle, which is the formulation least likely to overcome the barriers described above.

NAD+ Nasal Spray vs Injection

This comparison is searched about 250 times per month. Here's how the two routes stack up on what we actually know.

Injectable NAD+ at least delivers the molecule directly into tissue, even though no RCT has characterized the clinical outcomes. Nasal spray adds the absorption uncertainty on top of the outcomes uncertainty. You're stacking two unknowns instead of one.

The one scenario where nasal spray would have a genuine edge: if it can reach the brain faster or more effectively than any other route. That is the selling point of intranasal NAD+, and it is the claim with the least evidence behind it. The Berven study showed oral NR reaches the brain eventually (4 weeks). Whether a nasal spray gets there faster, and whether getting there faster matters clinically, are open questions.

NAD+ Nasal Spray Side Effects

No formal safety data exists for NAD+ nasal spray. What is reported comes from user experiences and compounding pharmacy disclosures:

• Nasal irritation or burning (the most commonly reported effect)
• Stinging sensation in the nasal passages, especially with unbuffered formulations
• Headache (reported occasionally, mechanism unclear)
• Runny nose or sneezing after application
• Unpleasant taste (postnasal drip can carry the NAD+ to the back of the throat)

These are consistent with the general side-effect profile of intranasal drug delivery. The nasal mucosa is sensitive tissue, and introducing any bioactive compound at pharmacological concentrations will cause some local irritation in some users.

Whether NAD+ nasal spray carries the same systemic side-effect profile as injectable NAD+ (chest tightness, nausea) is unknown. If meaningful amounts of NAD+ are reaching the bloodstream through the nose, those systemic effects could theoretically occur. If the spray is not achieving significant absorption, the side effects you experience are limited to local nasal irritation.

For a complete side-effect breakdown across all NAD+ delivery methods, see NAD+ Side Effects: What Clinical Trials Report.

NAD+ Nasal Spray Dosage

Common products deliver 10 mg of NAD+ per spray pump. Typical usage instructions call for 1 to 2 sprays per nostril, once or twice daily. That works out to 40 to 80 mg of NAD+ applied to the nasal mucosa per day at the standard dosing, or up to 200 mg per day at the higher end of what some vendors suggest.

A 10 mL bottle at 10 mg per spray contains roughly 100 sprays, lasting 12 to 25 days depending on your dosing frequency. Prices run $60 to $150 per bottle. For how nasal spray pricing compares with IV drips, injections, and oral capsules, see our NAD+ therapy cost guide.

There is no published dosing protocol based on clinical evidence. The doses listed above come from product labels and compounding pharmacy recommendations, not from trials that measured what dose produces a measurable effect. Without pharmacokinetic data showing how much NAD+ actually reaches the bloodstream or brain at a given nasal dose, optimal dosing cannot be determined from evidence.

One practical consideration the dosing labels rarely mention: the amount listed on the label is the amount in the spray, not the amount that reaches your bloodstream or brain. This is the same issue that undermines patch dosing. A label claiming "10 mg per spray" tells you what left the bottle, not what crossed the nasal mucosa. Because no absorption study exists for any NAD+ nasal spray, the effective dose is genuinely unknown. You could be absorbing most of it, a fraction, or very little, and the label number provides no guidance. Compare this to oral NMN, where a 500 mg capsule delivers a quantified amount through a route validated in dozens of trials that measured the resulting blood NAD+ increase. The nasal number is a manufacturing spec; the oral number connects to actual pharmacokinetic data.

For dosing details on all NAD+ delivery methods (oral, injection, IV, nasal), see NAD+ Dosage: Oral, Injection & IV Dosing Guide.

NAD+ Nasal Spray Benefits: What People Claim vs What's Proven

Sellers and users of NAD+ nasal spray claim benefits including improved mental clarity, faster cognitive function, better energy, enhanced focus, and neuroprotective effects. Some marketing goes further and suggests nasal NAD+ specifically benefits brain health because of the nose-to-brain delivery pathway.

What's proven: none of the above, for NAD+ nasal spray specifically. The underlying biology of NAD+ (it powers 500+ metabolic reactions, activates sirtuins, fuels DNA repair) is well established. The benefits of raising NAD+ levels have some clinical support from oral precursor trials (modest improvements in insulin sensitivity, exercise capacity, and sleep quality in individual studies). But attributing those benefits to a nasal spray that hasn't been shown to deliver NAD+ to any tissue is extrapolation, not evidence.

The nose-to-brain claim is the most interesting and the least proven. If intranasal NAD+ can bypass the blood-brain barrier and deliver NAD+ directly to brain tissue, it could be relevant for Alzheimer's and Parkinson's research, where brain NAD+ depletion is documented. A March 2026 expert review in Nature Aging identified NAD+ as a research priority for neurodegeneration. But that review discussed NAD+ in general, not nasal spray, and no clinical trial has tested intranasal NAD+ for any neurological condition.

For a full overview of what NAD+ does and what the evidence supports, see What Is NAD+? Benefits, Function & Why It Declines With Age.

Best NAD+ Nasal Spray: What to Look For

If you decide to try NAD+ nasal spray despite the evidence gap, here are the quality markers that distinguish one product from another.

Look for products from licensed compounding pharmacies rather than unregulated online retailers. Compounding pharmacies operate under state board of pharmacy oversight and follow USP standards for sterile preparations. An online supplement retailer selling a "nasal spray" may not meet the same quality controls for a product you're putting in your nose.

Check whether the product specifies its NAD+ concentration per spray (mg per actuation). Products that list total NAD+ per bottle without specifying per-spray dosing make it hard to control how much you're applying.

Ask whether the formulation includes penetration enhancers or buffering agents. A pH-buffered formulation (around pH 5.5 to 6.5, matching the nasal mucosa's natural pH) will cause less irritation than an unbuffered one. Some formulations include cyclodextrins or chitosan as absorption enhancers, which are used in approved intranasal drug products.

No brand of NAD+ nasal spray has published clinical trial data. This means "best" cannot be determined by evidence. You're choosing between unvalidated products and evaluating on formulation quality, pharmacy credentials, and transparency rather than proven efficacy.

A few additional markers worth checking. Look at the concentration: products commonly list around 10 mg per spray, but some are far more dilute, meaning you would need many more sprays to reach the same nominal dose. Check whether the product specifies the form of NAD+ or precursor it contains. As with patches, some "NAD+ nasal sprays" actually contain NMN or NR rather than NAD+ itself, and those smaller molecules face slightly different (though still unproven) absorption dynamics. Verify the pharmacy or manufacturer follows sterile compounding standards, since anything sprayed into the nasal cavity should meet appropriate quality controls for a mucosal product.

Be skeptical of specific health claims. A product that promises improved cognition, reversed brain aging, or enhanced focus is making claims that no clinical trial supports for nasal NAD+. Under FDA rules, dietary supplements cannot legally claim to treat, cure, or prevent disease, and specific cognitive-enhancement claims tied to a nasal delivery mechanism that has never been tested should raise a flag about the manufacturer's overall credibility.

Why Oral NMN or NR Is Still the Evidence-Based Starting Point

This section exists because most people searching for NAD+ nasal spray are looking for a way to raise their NAD+ levels, and the nasal spray is one of many delivery options they're evaluating. If your primary goal is NAD+ elevation backed by published evidence, oral NMN and NR are where you start.

The January 2026 head-to-head trial (Christen et al., Nature Metabolism) showed both NMN and NR approximately doubled blood NAD+ within 14 days at 1,000 mg/day. Thirty-plus human trials have established the safety profile. Monthly costs run $30 to $60. No prescription needed. No syringe. No nose burning.

Nasal spray might turn out to be useful for specific applications, particularly if the nose-to-brain delivery pathway is eventually validated for NAD+. But until that validation happens in a published human study, oral supplementation is the option with data behind it.

Intranasal Drugs That Do Work: The Comparison That Matters

Intranasal delivery is not snake oil. It is a legitimate, FDA-approved route for a growing list of drugs. Understanding why those work helps explain why NAD+ nasal spray is a different situation.

Several intranasal drugs have proven themselves in randomized controlled trials and earned regulatory approval. Zolmitriptan and sumatriptan nasal sprays treat migraines. Naloxone nasal spray (Narcan) reverses opioid overdoses. Desmopressin nasal spray manages certain hormone disorders. Esketamine nasal spray (Spravato) treats resistant depression. Intranasal oxytocin is used in research settings. Each of these went through formal pharmacokinetic studies proving the drug crosses the nasal mucosa and reaches its target at therapeutic concentrations.

What these successful intranasal drugs have in common tells you what NAD+ is up against. Most are relatively small and lipophilic, which helps them cross the nasal epithelium. They are formulated specifically for nasal absorption, often with penetration enhancers or specialized devices. And critically, each one was tested in humans with the specific nasal formulation, not assumed to work based on the drug's effects through other routes.

NAD+ meets none of these criteria as currently sold. It is large (663 Da) and hydrophilic, the opposite of the ideal profile for nasal absorption. Most consumer products are simple solutions without documented penetration enhancers. And no human study has tested any NAD+ nasal formulation for absorption or effect. The contrast is not that intranasal delivery does not work. It is that intranasal delivery of this specific molecule, in these specific products, has never been demonstrated to work.

This is the same pattern seen with NAD+ patches: a legitimate delivery technology (transdermal, or here intranasal) gets applied to a molecule whose physical properties make it a poor fit, sold without the absorption data that would prove the application succeeded. The delivery route works for other drugs. Whether it works for NAD+ is the unanswered question.

Is NAD+ Nasal Spray Worth Trying?

If your goal is raising NAD+ levels with evidence behind it, no. The evidence does not exist, and the molecular properties of NAD+ make nasal absorption an uphill battle that no manufacturer has shown their product overcomes.

If you are specifically interested in the theoretical brain-access advantage and you understand you are experimenting without data, that is a personal choice. The nasal spray is unlikely to cause serious harm beyond local irritation, and the cost is moderate. But you would be paying for a delivery mechanism whose central promise, direct brain access, has not been demonstrated for NAD+ and whose basic absorption has not been measured.

If you have not started any NAD+ supplementation, the decision is straightforward. Oral NMN and NR have 30-plus human trials, proven blood NAD+ elevation, established safety profiles, and lower cost. The Berven 2026 study even showed oral NR reaches the brain after four weeks, which undercuts one of the main theoretical arguments for the nasal route. Start with what is proven.

The honest bottom line: NAD+ nasal spray is one of the least-evidenced NAD+ delivery methods on the market, sitting alongside patches in the "theoretically interesting, clinically unproven" category. That may change if a manufacturer runs the studies. Until then, it is a bet, not a strategy.

Frequently Asked Questions

Does NAD nasal spray work?

Unknown. No published human trial has measured whether NAD+ from a nasal spray enters the bloodstream or produces any measurable health outcome. The intranasal route is theoretically plausible based on how other drugs absorb through the nasal mucosa, but this has not been confirmed for NAD+.

What are NAD+ nasal spray side effects?

Reported effects include nasal irritation, burning, stinging, headache, runny nose, and unpleasant taste from postnasal drip. No formal clinical safety data exists. If the spray achieves significant systemic absorption, systemic side effects (nausea, chest tightness) could theoretically occur.

What is the NAD+ nasal spray dosage?

Common products deliver 10 mg per spray. Typical usage: 1 to 2 sprays per nostril, once or twice daily (40 to 80 mg/day). No clinical trial has established an optimal dose. These numbers come from product labels, not evidence.

Is NAD+ nasal spray better than oral NMN?

Not based on current evidence. Oral NMN has 12+ human RCTs showing it raises blood NAD+. NAD+ nasal spray has zero trials. The nasal route might eventually prove useful for brain-specific applications, but that remains a hypothesis.

Can NAD+ nasal spray reach the brain?

Theoretically yes, through the olfactory nerve pathway that connects the upper nasal cavity to the brain. This route has been demonstrated for other molecules. It has not been demonstrated for NAD+. The Berven 2026 study showed oral NR reaches the brain after 4 weeks, providing a comparison point that nasal spray has not been tested against.

Where can I buy NAD+ nasal spray?

Through licensed compounding pharmacies (typically with a physician's prescription) or specialty supplement retailers online. Quality varies significantly. Look for pharmacies that operate under USP standards and specify NAD+ concentration per spray actuation.

How do you use NAD+ nasal spray?

Manufacturers typically direct users to prime the pump, insert the nozzle into one nostril while closing the other, spray while inhaling gently, and repeat in the other nostril. Common dosing is 1 to 2 sprays per nostril once or twice daily. Tilting the head and aiming toward the top of the nasal cavity is sometimes suggested to reach the olfactory region, though whether this meaningfully improves delivery from a consumer device is unproven.

Does NAD+ nasal spray have systemic side effects?

If the spray achieves meaningful systemic absorption, the same effects seen with other NAD+ delivery methods (flushing, nausea) are theoretically possible. In practice, most reported effects are local: nasal irritation, burning, and runny nose. The absence of strong systemic effects may itself suggest limited systemic absorption, though no study has measured this directly.

Can NAD+ nasal spray help with brain fog or focus?

These are among the most common marketing claims, based on the theory that nasal delivery reaches the brain directly. No clinical trial has tested NAD+ nasal spray for cognitive effects. Any reported benefit is anecdotal and could reflect placebo, systemic absorption, or other factors. The underlying idea (that brain NAD+ supports cognitive function) has some basis, but the delivery method's ability to raise brain NAD+ is unproven.

How much does NAD+ nasal spray cost?

Typically $60 to $150 per bottle, with a bottle lasting roughly 12 to 25 days depending on dosing frequency. This is more expensive per month than oral NMN ($30 to $60) and, unlike oral supplements, comes without clinical evidence of efficacy.

Is NAD+ nasal spray FDA approved?

No. NAD+ nasal sprays are sold as supplements or through compounding pharmacies, neither of which requires FDA approval for efficacy. No NAD+ nasal spray has been evaluated or approved by the FDA. This differs from FDA-approved intranasal drugs like naloxone or esketamine, which underwent formal clinical trials.

NAD+ nasal spray vs oral: which absorbs better?

Oral NAD+ precursor absorption is documented in 30-plus human trials showing roughly 2x blood NAD+ elevation within 14 days. Nasal NAD+ absorption has never been measured in a published human study. "Better" cannot be determined from evidence, but oral is the only route with proven absorption data.

Related Reading

• What Is NAD+? Benefits, Function & Why It Declines With Age
• NAD+ Dosage: Oral, Injection & IV Dosing Guide
• NAD+ Side Effects: What Clinical Trials Report
• NAD+ Injections: Benefits, Side Effects & Cost
• NAD+ IV Therapy: How It Works, Costs & Evidence
• NAD+ Patches: Do They Work?
• Is NAD+ a Peptide? No. Here's What It Actually Is
• NAD+ Supplements: Types, Evidence & How to Choose
• Best NMN Supplements in 2026
• Best NAD+ Supplements in 2026

References

1. Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. 2026;116:103057. doi:10.1016/j.arr.2026.103057 View source (PubMed)
2. Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026;8:62-73. doi:10.1038/s42255-025-01421-8 View source (PubMed)
3. Berven H, Svensen M, Eikeland H, et al. The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation. iScience. 2026;29(3):114764. doi:10.1016/j.isci.2026.114764 View source (PubMed)
4. Vinten KT, Trętowicz MM, Coskun E, et al. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nature Metabolism. 2025;7(10):1974-1990. doi:10.1038/s42255-025-01387-7 View source (PubMed)
5. Qiu Y, Huang S, Peng L, et al. The nasal-brain drug delivery route: mechanisms and applications to central nervous system diseases. MedComm. 2025;6(6):e70213. doi:10.1002/mco2.70213 View source (PubMed)
6. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9:1286. doi:10.1038/s41467-018-03421-7 View source (PubMed)

Written by Tao Wu. Last reviewed September 2026. This article is for informational purposes and does not constitute medical advice. Talk to your doctor before starting any new supplement.